AbCellera Biologics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $6.05 on 01/08/24, and the lowest price during the same period was recorded at $2.34 on 09/10/24.
52-week price history of ABCL Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. AbCellera Biologics Inc’s current trading price is -55.41% away from its 52-week high, while its distance from the 52-week low is 15.63%. The stock’s price range during this period has fluctuated between $2.34 and $6.05. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.25 million for the day, which was evidently higher than the average daily volume of 1.81 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
AbCellera Biologics Inc (ABCL) has experienced a quarterly decline of -17.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 795.61M and boasts a workforce of 586 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.82, with a change in price of -1.18. Similarly, AbCellera Biologics Inc recorded 1,848,233 in trading volume during the last 100 days, posting a change of -30.41%.
ABCL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABCL Stock Stochastic Average
The raw stochastic average for AbCellera Biologics Inc over the last 50 days is presently at 61.86%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 56.86%. Further, the company’s Stochastic %K and %D values for the last 20 days were 71.24% and 76.89%, respectively.
ABCL Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -52.71% this year. Over the last six months, there has been a stronger performance of -25.62%. The price of ABCL fallen by 10.66% during the last 30 days period. For the last 5-days stocks have improved 0.75%.
